Picture 1.png

A new approach to de-risk your development and commercialisation journey, taking advantage of your data

 

In 2021, 30% of studies reviewed for FDA approval received a Complete Response Letter

Causal Analysis is an emerging technique used in several industries already, and is recognised by the FDA

Causal AI appears on Gartner’s 2022 Hype Cycle for Emerging Technologies

Gartner Hype Cycle.jpeg

incubate.bio has built a computational platform called ALaSCA to rapidly apply Causal Discovery and Causal Inference with biological data and RWD

Screenshot 2022-08-31 at 3.55.32 pm.png

Antimicrobial Resistance Case Study
 

Common causal questions asked
 

Contact us for more info: raminderpal@incubate.bio